Multicenter Randomized Trial of Methylprednisolone vs. Intravenous Immunoglobulins to Treat the Pediatric Inflammatory Multisystem Syndrome-Temporally Associated With SARS-CoV-2 (PIMS-TS): Protocol of the Swissped RECOVERY Trial

• Main Authors: Tatjana Welzel (Author), Nina Schöbi (Author), Maya C. André (Author), Douggl G. N. Bailey (Author), Geraldine Blanchard-Rohner (Author), Michael Buettcher (Author), Serge Grazioli (Author), Henrik Koehler (Author), Marie-Helene Perez (Author), Johannes Trück (Author), Federica Vanoni (Author), Petra Zimmermann (Author), Andrew Atkinson (Author), Carlos Sanchez (Author), Elizabeth Whittaker (Author), Saul N. Faust (Author), Julia A. Bielicki (Author), Luregn J. Schlapbach (Author), the Swissped Recovery Trial (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

IntroductionIn 2020, a new disease entitled Pediatric Inflammatory Multisystem Syndrome temporally associated with COVID-19 (PIMS-TS), or Multisystem Inflammatory Syndrome in Children (MIS-C), emerged, with thousands of children affected globally. There is no available evidence based on randomized c...